New Results
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152
Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Dharam, Narasimha Reddy Molugu, Sai D Prasad, Srinivas Vellimudu, Krishna M Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, View ORCID ProfileRaches Ella, Priya Abraham, Pragya Yadav, Gajanan N Sapkal, Anita Shete, Gururaj Rao Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta, Krishna Mohan Vadrevu
doi: https://doi.org/10.1101/2020.09.09.285445
Brunda Ganneru
1Bharat Biotech International Ltd, Hyderabad, India
Harsh Jogdand
1Bharat Biotech International Ltd, Hyderabad, India
Vijaya Kumar Dharam
1Bharat Biotech International Ltd, Hyderabad, India
Narasimha Reddy Molugu
1Bharat Biotech International Ltd, Hyderabad, India
Sai D Prasad
1Bharat Biotech International Ltd, Hyderabad, India
Srinivas Vellimudu
1Bharat Biotech International Ltd, Hyderabad, India
Krishna M Ella
1Bharat Biotech International Ltd, Hyderabad, India
Rajaram Ravikrishnan
2RCC Labs, Hyderabad, Faridabad, India
Amit Awasthi
3Translational Health Sciences and Technology Institute, Faridabad, India
Jomy Jose
2RCC Labs, Hyderabad, Faridabad, India
Panduranga Rao
1Bharat Biotech International Ltd, Hyderabad, India
Deepak Kumar
1Bharat Biotech International Ltd, Hyderabad, India
Raches Ella
1Bharat Biotech International Ltd, Hyderabad, India
Priya Abraham
4National Institute of Virology-Indian Council of Medical Research, India
Pragya Yadav
4National Institute of Virology-Indian Council of Medical Research, India
Gajanan N Sapkal
4National Institute of Virology-Indian Council of Medical Research, India
Anita Shete
4National Institute of Virology-Indian Council of Medical Research, India
Gururaj Rao Desphande
4National Institute of Virology-Indian Council of Medical Research, India
Sreelekshmy Mohandas
4National Institute of Virology-Indian Council of Medical Research, India
Atanu Basu
4National Institute of Virology-Indian Council of Medical Research, India
Nivedita Gupta
5Indian Council of Medical Research, India
Krishna Mohan Vadrevu
1Bharat Biotech International Ltd, Hyderabad, India
Article usage
Posted September 12, 2020.
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152
Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Dharam, Narasimha Reddy Molugu, Sai D Prasad, Srinivas Vellimudu, Krishna M Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, Raches Ella, Priya Abraham, Pragya Yadav, Gajanan N Sapkal, Anita Shete, Gururaj Rao Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta, Krishna Mohan Vadrevu
bioRxiv 2020.09.09.285445; doi: https://doi.org/10.1101/2020.09.09.285445
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152
Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Dharam, Narasimha Reddy Molugu, Sai D Prasad, Srinivas Vellimudu, Krishna M Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, Raches Ella, Priya Abraham, Pragya Yadav, Gajanan N Sapkal, Anita Shete, Gururaj Rao Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta, Krishna Mohan Vadrevu
bioRxiv 2020.09.09.285445; doi: https://doi.org/10.1101/2020.09.09.285445
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)